rs118203378
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_000368.5(TSC1):c.381_383delTGT(p.Val128del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000368.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC1 | ENST00000298552.9 | c.381_383delTGT | p.Val128del | disruptive_inframe_deletion | Exon 6 of 23 | 1 | NM_000368.5 | ENSP00000298552.3 | ||
TSC1 | ENST00000490179.4 | c.381_383delTGT | p.Val128del | disruptive_inframe_deletion | Exon 7 of 24 | 3 | ENSP00000495533.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tuberous sclerosis syndrome Other:2
- -
- -
Tuberous sclerosis 1 Pathogenic:1
This variant, c.381_383del, results in the deletion of 1 amino acid(s) of the TSC1 protein (p.Val128del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with tuberous sclerosis and/or tuberous sclerosis complex (PMID: 18830229; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as c.379_381delTGT (p.128delV). ClinVar contains an entry for this variant (Variation ID: 49038). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects TSC1 function (PMID: 21309039). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.381_383delTGT variant (also known as p.V128del) is located in coding exon 4 of the TSC1 gene. This variant results from an in-frame TGT deletion at nucleotide positions 381 to 383. This results in the in-frame deletion of a valine at codon 128. This variant has been reported in individuals with features consistent with a clinical diagnosis of tuberous sclerosis complex (TSC) (Nellist M et al. Eur J Hum Genet, 2009 Mar;17:319-28; external communication). In addition, this alteration was identified in 1 of 374 patients with clinically suspected TSC undergoing genetic testing within the TSC1 and TSC2 genes (Meng Y et al. J Hum Genet, 2021 Mar;66:227-236). Functional studies have reported a deleterious impact for this variant (Nellist M et al. Eur J Hum Genet, 2009 Mar;17:319-28; Hoogeveen-Westerveld M et al. Hum Mutat, 2011 Apr;32:424-35). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at